Overview To Demonstrate the Relative Bioavailability of Cefzil 250 mg/5 ml Cefprozil Oral Suspension Fed Conditions Status: Completed Trial end date: 2004-06-01 Target enrollment: Participant gender: Summary To demonstrate the relative bioavailability of Cefzil 250 mg/5 ml oral suspension fed conditions. Phase: Phase 1 Details Lead Sponsor: SandozTreatments: CefprozilCephalosporins